Advocacy intelligence hub — real-time data for patient organizations
University Hospital, Lille — PHASE2
Assistance Publique - Hôpitaux de Paris — NA
Vitruvian Medical Devices, Inc. — PHASE1
University of Southern California — EARLY_PHASE1
University Hospital, Lille
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Drug reaction with eosinophilia and systemic symptoms news →
Sophie DUVERT-LEHEMBRE, MD
University Hospital, Rouen
Delphine Staumont-Salle, MD,PhD
University Hospital, Lille
Pascal DEMOLY, MD, PhD
University Hospital, Montpellier
Jettanong klaewsongkram, MD
Chulalongkorn University
Kanade Shinkai
University of California
📍 SAN FRANCISCO, CA
Elizabeth J Phillips
Institute for Immunology and Infectious Diseases
View all Drug reaction with eosinophilia and systemic symptoms specialists →